Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload (Q79833216)
Jump to navigation
Jump to search
scientific article published on 01 July 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload |
scientific article published on 01 July 2006 |
Statements
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload (English)
Antonio Piga
Renzo Galanello
Gian Luca Forni
Maria Domenica Cappellini
Raffaella Origa
Antonietta Zappu
Guido Donato
Elena Bordone
Antonella Lavagetto
Laura Zanaboni
Romain Sechaud
Nicola Hewson
John M Ford
Herbert Opitz
Daniele Alberti